22nd Century集团宣布，其VLN®减害烟草产品（MRTP）的续期申请已正式提交美国食品药品监督管理局（FDA）进行科学审查。此举标志着公司在推进其低尼古丁烟草产品监管进程中的又一重要步骤。
22nd Century集团宣布，其VLN®减害烟草产品（MRTP）的续期申请已正式提交美国食品药品监督管理局（FDA）进行科学审查。此举标志着公司在推进其低尼古丁烟草产品监管进程中的又一重要步骤。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.